Optimal co-development contracts for companion diagnostics
The market for companion diagnostics is expected to be a US $10.07 billion by 2026.
Companion diagnostics have the potential to make expensive drugs cost-effective by …
Companion diagnostics have the potential to make expensive drugs cost-effective by …
Regulated pricing decisions and diagnostic test choices in personalized medicine: Navigating the implications within legal frameworks
Z Cui, X Liu, Z Feng, Z Huang - Risk Management and Healthcare …, 2024 - Taylor & Francis
Background The emerging risk of personalized medicine is driving drug manufacturers to
seek collaborations with advanced diagnostic firms, aiming to improve detection and …
seek collaborations with advanced diagnostic firms, aiming to improve detection and …